DUBLIN–(BUSINESS WIRE)–The “Global Therapeutic Antibody Market (2023 Edition): Analysis By Antibody Type (Monoclonal, Bispecific, Drug Conjugates, Others), Source (Fully human, Humanized, Others), By Application, By Region, By Country: Market Insights and Forecast (2019-2029)” report has been added to ResearchAndMarkets.com’s offering.
Global Therapeutic Antibody Market reveals significant insights into market segmentation, including monoclonal antibodies, bispecific antibodies, and more. The study covers antibody sources like fully human and humanized antibodies, and applications such as oncology and autoimmune diseases.
This in-depth report examines the forecast growth trends and market dynamics from 2024 to 2029, with a specific focus on key regions and countries contributing to the global market expansion. The report identifies a robust compound annual growth rate (CAGR) of 11.21% during the forecast period.
Highlighted within the report are the key drivers influencing the market’s trajectory, including the rising prevalence of chronic diseases and the leap forward in personalized medicine. Moreover, the market analysis showcases how the COVID-19 pandemic has accelerated the development and usage of therapeutic antibodies, reflecting the industry’s ability to rapidly respond to emergent health issues.
Within the report, advancements in antibody engineering are emphasized, demonstrating how novel antibody formats and improvements in specificity and affinity lead to enhanced therapeutic interventions. These developments are poised to further revolutionize healthcare outcomes, offering tailored treatments with minimal side effects.
- The report provides a comprehensive market value analysis (USD Billion).
- A detailed review is presented, inclusive of the historical period from 2019-2022 and the forecast period from 2024-2029.
- The market is analyzed by product type, source, and application, offering a thorough understanding of the therapeutic antibody landscape.
Strategic industry analysis through SWOT and Porter’s Five Forces is included, equipping stakeholders with essential tools for decision-making. The attractiveness of the market is assessed by region, services, and other crucial categories.
The report also tracks competitive strategies, mergers and acquisitions, and new product developments among key players in the market. Through a careful examination of industry trends, drivers, and challenges, the report provides an insightful forecast and analysis that bolsters understanding of the Global Therapeutic Antibody Market’s future trajectory.
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 260 |
| Forecast Period | 2024 – 2029 |
| Estimated Market Value (USD) in 2024 | $251.77 Billion |
| Forecasted Market Value (USD) by 2029 | $428.2 Billion |
| Compound Annual Growth Rate | 11.2% |
| Regions Covered | Global |
Companies Mentioned
- F. Hoffmann-La Roche AG
- Bristol-Myers Squibb Co.
- AbbVie Inc.
- Merck & Co., Inc.
- Johnson & Johnson
- Novartis
- Regeneron Pharmaceuticals
- Takeda Pharmaceuticals
- Amgen, Inc.
- Eli Lilly and Company
Key Market Insights
The research offers a detailed analysis of the therapeutic antibody market by product type:
- Monoclonal antibody
- Bispecific antibody
- Antibody drug conjugates
- Others
It also examines the source of antibodies:
- Fully human
- Humanized
- Others
And it explores various applications:
- Oncology
- Autoimmune
- Infectious disease
- Others
For more information about this report visit https://www.researchandmarkets.com/r/g6rvnv
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
